AllDocs -> heart diseases

Introduction Definition of isolated systolic hypertension (ISH) according to JNC-VI (1) and 1999 WHO/ISH (2): systolic blood pressure (SBP) =140 mm Hg, diastolic blood pressure <90 mmHg. Accordingly, the different grades of ISH are defined as follows: Pathogenetic factors: Age-related vascular and neuro- humoral changes are important factors leading to the develop- ment of hypertension and particularly of ISH. Arterial compli- ance deteriorates because of structural and functional changes and increases is collagen, extracellular protein matrix, ground substance, elastin that occur with age. These changes create structural and mechanical alterations in the vessel intima and media. Calcium binds to the elastin, and undifferentiated muscle cells of the media proliferate and migrate through the elastic laminae to the intima. The prolifer- ation of the connective tissue results in intimal thickening ...

Hypertensive disorders in pregnancy remain a major cause of maternal, fetal and neonatal morbidity and mortality not only in less developed but, also, in the industrialized countries. Pregnant women with hypertension are at higher risk for severe complica- tions such as abruptio placentae, cerebrovascular accident, organ failure, and disseminated intravascular coagulation. The fetus is at risk for intrauterine growth retardation, prematurity, and intrauter- ine death. Physiologically, blood pressure falls in the second trimester, reaching a mean of 15 mmHg lower than levels before pregnancy. In the third trimester, it returns to pre-pregnancy levels. This fluc- tuation occurs in both normotensive and chronically hypertensive women. Definition of hypertension in pregnancy The definition of hypertension in pregnancy is not uniform. It used to include an elevation in blood pressure during the second ...

HYPERTENSION IN CHRONIC RENAL FAILURE. Jose L. Rodicio and Jose M. Alcazar, Department of Nephrology. Hospital 12 de Octubre, Madrid, Spain Introduction. When compared with essential arterial hyper- tension, the incidence of secondary arterial hypertension is low (8-10%), but it can be cured by surgery in the case of ren- ovascular hypertension , renin producing tumors, coartaction of the aorta and some types of suprarenal gland diseases. The most frequent form of secondary hypertension is caused by chronic renal parenchymatous injury, which occurs in approximately 5% of all cases of hypertension . Table I pres- ents the most frequent causes of this type of hypertension . As the renal insufficiency progresses, the percentage of patients who suffer arterial hypertension increases; about 85-90% of the patients in end-stage chronic renal failure present elevat- ed blood pressure levels ...

HOW TO HANDLE RENOVASCULAR HYPERTENSION Jose M. Alcazar and Jose L. Rodicio, Department of Nephrology. Hospital 12 de Octubre, Madrid, Spain Introduction. Renovascular hypertension (RVH) is defined as the elevation of arterial pressure precipitated by a hemody- namically significant stenosis of a renal artery or arteries (that is, stenosis caliber greater than 75% of the vessel lumen or than 50% with post-stenotic dilation). When the lesion affects both renal arteries or a single functioning kidney and is accom- panied by renal failure (plasma creatinine concentration above 1.5 mg/dl), it is called ischemic nephropathy (1,2). The rate of renovascular hypertension (RVH) is less than 1% when a mild-moderate hypertension population is assessed but this increases according to the severity of the hypertension and population age (3). In 4,429 patients with arterial hypertension , Anderson ...

PATIENT COMPLIANCE IN THE TREATMENT OF ARTERIAL HYPERTENSION JM. Mallion*, D. Schmitt° * Cardiologie et Hypertension Artérielle, CHU de Grenoble, BP 217 x - 38043 France ° Département de Pharmacie, CHU Grenoble, BP 217 x - 38043 France Introduction: Arterial hypertension (HT) is a major cardiovas- cular and cerebrovascular risk factor and a condition which is very prevalent throughout the world involving 50% of those over 60 years of age. Despite the fact that there are constant- ly improving treatments available only one third of patients who are treated have a normalisation of blood pressure (BP). This is a worrying finding since it is proven that achieving nor- mal BP can reduce consequent neurological, cardiac and vas- cular effects. One explanation of this lack of efficacy is undoubtedly poor therapeutic compliance with antihypertensive treatment. The sixth report of the Joint ...

American Journal of Hypertension 2004;17 (5):196A-197A. Abstract P-445. Health Care Costs Related to Multi-Drug Treated Hypertensives in the Medicare Population John Flack, Roy C. Martin, Mary E. McGrory-Usset, Internal Medicine, Wayne State University, Detroit, MI; CVRx, Inc. Maple Grove, MN CVRx, Inc. Maple Grove, MN. To identify costs related to managing multi-drug treated hypertension patients with and without co-morbidities, an historical claims-based study was conducted by the United HealthGroup. A random sample of 5% of the eligible Medicare Fee-For-Service population was purchased from CMS and a managed care database of 500,000 Medicare eligible lives were used. The claims from these databases included 1.9 million covered Medicare lives during the entire 12 month period in 2001. The claims were analyzed to identify patients who had a diagnosis of hypertension and were on > 3 hypertension ...

Hypertension Management Guide for Doctors 2004 Heartline 1300 36 27 87 Heartsite www.heartfoundation.com.au Page 2 Page 1 Contents Summary points 2 General principles 3 Absolute cardiovascular risk 4 How to measure blood 8 pressure accurately Guide to diagnostic levels 10 Diagnostic evaluation in patients 11 with confirmed hypertension When to intervene 13 Clinic treatment goals (mm Hg) 14 Lifestyle modifications to reduce 14 blood pressure and absolute cardiovascular disease risk Drug treatment 17 How to use medication 19 When initial drug treatment fails 21 (resistant hypertension ) and for ‘loss of control’ Long term follow-up 22 Process for developing ...

1. For more information contact Heartline 1300 362 787 or www.heartfoundation.com.au Information from the I N F O R M A T I O N Non-drug management of hypertension Professor LJ Beilin MA (Oxon), MB, BS, FRCP, FRACP, Dept of Medicine, Royal Perth Hospital, Perth. Professor GL Jennings, MD, FRCP, FRACP, Baker Heart Research Institute, Melbourne. A variety of non-pharmacological measures have an important role in the management of patients with hypertension . These include weight management, dietary sodium restriction, regular physical activity, moderation of alcohol consumption, healthy eating and avoidance of smoking. Used effectively, these measures may abolish the need for antihypertensive drugs in some patients with mild hypertension and will help minimise antihypertensive drug requirements ...

National Blood Pressure Advisory Committee (Key Author Group) Prof Lindon Wing MBBS FRACP Committee Chair and Dean of School of Medicine, Principal author Flinders University, Adelaide, SA. Prof Anthony Dart BA BM BCh FRCP FRACP DPhil Associate Director, Baker Heart Research Institute, Melbourne VIC. A/Prof Karen Duggan MD FRACP Associate Professor of Medicine, University of New South Wales, and Director Hypertension Service, South Western Sydney Area Health Service, NSW. Prof Graeme Hankey MD FRCP FRACP Neurologist and Head of Stroke Unit, Royal Perth Hospital; and Clinical Professor, School of Medicine and Pharmacology, University of Western Australia, Perth, WA. Dr Mark Nelson MBBS(Hons) MFM FRACGP FAFPHM PhD NHMRC Fellow Dept Epidemiology and Preventive Medicine, and Senior Research Fellow, Dept ...

UNDER EMBARGO Strictly not for publication - before Tuesday 9 December 2003 HEART FOUNDATION LAUNCHES NEW HYPERTENSION GUIDELINES The National Heart Foundation of Australia today launched the Hypertension Management Guide for Doctors 2004 , an essential resource for all general practitioners and other health professionals involved in the management of hypertension . The guide provides updated patient assessment and management recommendations including an emphasis on lifestyle modifications as first line intervention, even when drug therapy is recommended. While highlighting that blood pressure is a major determinant of an individual’s absolute risk for cardiovascular events such as heart attack and stroke, the guide stresses the importance of a comprehensive approach to management which addresses all cardiovascular risk factors, particularly in those at highest absolute risk. The ...

MissouriFamilies Learning Opportunities for Families http://missourifamilies.org University of Missouri ? Columbia ? Kansas City ? Rolla ? St. Louis ? Lincoln University ? Outreach & Extension Family Nutrition Education Program Diet and Disease Series University Outreach and Extension does not discriminate on the basis of race, color, national origin, sex, religion, age, disability or status as a Vietnam-era veteran in employment or programs. If you have special needs as addressed by the Americans with Disabilities Act and need this publication in an alternative format, write ADA Officer, 309 University Hall, Columbia, MO 65211. Hypertension Facts Tricia Fleming, University of Kansas Dietetic Intern, Tammy Beason, MS, RD, Nutrition Education Specialist, Family Nutrition Education Program. Editor: Candance Gabel, MS, RD, LD Associate State Nutrition Specialist, Family Nutrition ...

Hypertension in older adults NEW FACTS ABOUT R A pproximately 35 percent of community dwelling people over 65 years of age are hypertensive. 1,2 Similar prevalence rates are found among nursing home residents. 3 Hypertensive older adults experience cardiovascular events at a rate 2–3 times higher than that of younger individuals with the same sys- tolic and diastolic blood pressure. 4 Given these facts, interventions to prevent, diagnose, and treat hypertension could have a significant impact on morbidity and mortality among the elderly. The following are some important findings in the recent literature related to the process of care for hypertension : Nonpharmacologic therapies—diet (e.g., sodium restriction and weight loss) and exercise (e.g., aer- obic exercise)—are effective in lowering blood pressure, and may ...

hypertension 1581 Diet and Hypertension Created by: Tricia Fleming, University of Kansas Dietetic Intern Tammy Beason, MS, Nutrition Education Specialist, Family Nutrition Education Program December 2001 What is Blood Pressure? The force of blood against the wall of the arteries. Systolic- as the heart beats Diastolic - as the heart relaxes Written as systolic over diastolic. Normal Blood pressure is less than 130 mm Hg systolic and less than 85 mm Hg diastolic. High Blood Pressure A consistent blood pressure of 140/90 mm Hg or higher is considered high blood pressure. It increases chance for heart disease, kidney disease, and for having a stroke. 1 out of 4 Americans have High Bp. Has no warning signs or symptoms. Why is High Blood Pressure Important? Makes the Heart work too ...

Who Has Hypertension ? / Survey Results Visit http://www.MedicineNet.com for reliable doctor-produced health and medical information Copyright ©2005 by MedicineNet.com MedicineNet Health Research Survey Report Who Has Hypertension ? Survey Results Prepared by MedicineNet.com June 2005 All Rights Reserved http://www.medicinenet.com/hypertension_survey_results/arti cle.htm Page 2 Who Has Hypertension ? / Survey Results Page 2 Visit http://www.MedicineNet.com for reliable doctor-produced health and medical information Copyright ©2005 by MedicineNet.com Table of Contents Table of Contents. 2 Health Research Survey Reports . 4 Executive Summary 5 Methodology.. 6 THE SURVEY POPULATION.. 6 Findings. 8 AGE AND HYPERTENSION 8 PREVALENCE OF RISK FACTORS 9 TREATMENT OPTIONS .. 10 ...

Hypertension Research at the University of Sydney The University of Sydney is a fitting start for a series of articles about Hypertension Research in Australia. The Department of Physiology founded around 1890 has had a long history of research into cardiovascular disease and hypertension . Notably Past HBPRCA President, Professor Paul Korner graduated from The University of Sydney in Science and Medicine in the early 1950s, and obtained his clinical training at Royal Prince Alfred Hospital. He spent further periods in the Department of Physiology before moving to Melbourne in 1975 to head the Baker Institute. More recently, he has returned to Sydney and has been writing a major work on hypertension entitled “The Neurogenic Basis of Essential Hypertension ” which is in the very final stages with the publisher. Professor John Chalmers , also a past president of the society, who is now the Senior Director of ...

Produced by the Faculty of Public Health and the National Heart Forum A toolkit for developing a local strategy to tackle high blood pressure tackling hypertension pressure : easing the Page 2 Written by Dr Alan Maryon-Davis and Dr Vivienne Press on behalf of the Cardiovascular Health Working Group of the Faculty of Public Health A toolkit for developing a local strategy to tackle high blood pressure tackling hypertension easing the pressure : Produced by the Faculty of Public Health and the National Heart Forum Page 3 Easing the Pressure:Tackling Hypertension Text by Dr Alan Maryon-Davis and Dr Vivienne Press, on behalf of the Cardiovascular Health Working Group of the Faculty of Public Health Project management, and additional writing and research by Lindsey Stewart Edited and ...

Suggested structure for a local hypertension strategy H1 Tool Strategy section Sections of this toolkit that can help Introduction: the need for action The introduction to the strategy should outline the main elements and give the reasons why local action is necessary to tackle hypertension .For example: • national and local policy drivers • an estimate of the local prevalence and costs of hypertension • an outline of the benefits of preventing,detecting and controlling hypertension . Pages 33-35 Tool H1 Suggested structure for a local hypertension strategy Tool H2 National policy drivers (1) Tool H3 Hypertension prevalence ready-reckoner Strategic partnerships This section details the key partners who will help to plan,implement and evaluate the strategy,the establishment of a hypertension action ...

Hypertension June, 2004 (reformatted May, 2005) (Federal Bureau of Prisons - Clinical Practice Guidelines) Clinical guidelines are being made available to the public for informational purposes only. The Federal Bureau of Prisons (BOP) does not make any promise or warrant these guidelines for any other purpose, and assumes no responsibility for any injury or damage resulting from the reliance thereof. Proper medical practice necessitates that all cases are evaluated on an individual basis and treatment decisions are patient-specific. Page 2 i Hypertension June, 2004 (reformatted with minor changes May, 2005) (Federal Bureau of Prisons - Clinical Practice Guidelines) Table of Contents 1. Purpose 1 2. Diagnosis . 1 Diagnostic criteria 1 Methodology . 1 Screening 2 Diagnostic monitoring ...

Copyright: Council for Medical Schemes Page 1 of 4 HYPERTENSION Measure BP in sitting position Systolic<130mmHg and diastolic< 85 mmHg Recheck in 1 year Diabetes? CCF? Systolic 140-159mmHg or diastolic 90-99mmHg Recheck within 2 months Start drug treatment Start drug treatment NO NO YES YES Systolic>160mmHg and diastolic >100mmHg Systolic >140mmHg or diastolic > 90mmHg Systolic >140mmHg or diastolic > 90mmHg Target organ disease Lifestyle modifications Review in 6 months Initial drug choices (unless contraindicated) For uncomplicated hypertension Start with diuretic Compelling Indications YES NO Page 2 Copyright: Council for Medical Schemes Page 2 of 4 • Angina: ...

Idaho Drug Utilization Review Program Educational Leaflet HYPERTENSION : Information for the Patient What is hypertension ? Hypertension is also known as high blood pressure and occurs when the blood pressing on the inside of the arteries (blood vessels) is higher than normal. Untreated hypertension can have serious consequences including a higher risk for heart attacks, strokes, or kidney problems. Because people with hypertension often do not feel sick, it is sometimes referred to as the “silent killer.” What causes hypertension ? The cause of hypertension for most people is unknown, but we do know that there are some things that that can increase your risk, such as: Family history of hypertension High cholesterol Diabetes Smoking Being over 60 years old Measuring hypertension There are two numbers referred to when measuring a person’s ...

FOR IMMEDIATE RELEASE VSM MedTech to Sponsor World Hypertension Day – May 14, 2005 VANCOUVER, British Columbia (May 10, 2005) – VSM MedTech Ltd. (TSX:VSM) today announced that it is supporting Canadian activities associated with World Hypertension Day on Saturday, May 14, 2005. As part of the World Hypertension Day activities, representatives from VSM will visit Parliament Hill in Ottawa and measure the blood pressure of staff and dignitaries using the Company’s BpTRU™ family of automated, non-invasive blood pressure monitors. “As a risk factor for heart attacks, heart failure, strokes and kidney failure, hypertension is a serious condition affecting an estimated 5 million Canadians over the age of 18, almost half of which are not even aware that they are affected,” said Jack Price, VSM’s President and CEO. “We are proud to participate in this worldwide event aimed at increasing awareness of the serious ...

Updated February 2004 Bureau of Community and Environmental Health Past Lead Exposure and Hypertension : Information for Health Care Providers What is the relationship between past lead exposure and hypertension ? Studies have shown that populations exposed to moderate to high levels of lead are at an increased risk of hypertension , both during the exposure and later in life. The mechanism may be related to lead's effects on calcium and calcium-related processes in the body, although other mechanisms have also been hypothesized. While increases in individual risk are relatively small, the impact on public health can be substantial by increasing the incidence of a condition that is already widespread in the general population. Elevated blood pressure also increases the risk for more serious conditions (most notably heart disease, stroke, and renal disease). Reduction of risk for these more serious ...

AREA Male Female Male Female Male Female Male Female Male Female Male Female Male Female NUMBER RATE yrs. 5 - 14 15 - 49 50 - 64 65 yrs. NOTIFIABLE DISEASES: HYPERTENSION By Health Region, Province & City Philippines, 2002 By Age-Group and By Sex TOTAL BOTH SEXES 1 yr. yrs. TOTAL & above yrs. yrs. LESS THAN 1 - 4 PHILIPPINES 17 18 121 101 354 914 40,447 63,199 56,379 64,882 38,905 39,565 136,011 168,679 304,690 383.2 NAT. CAP. REGION 1 - 6 3 9 25 2,112 3,456 2,507 3,752 ...

10 TH ANNUAL HYPERTENSION SYMPOSIUM 2005 “CONTROVERSIES, DEBATES AND NEW TREATMENT GOALS TO REDUCE TARGET ORGAN DAMAGE IN HYPERTENSION , DYSLIPIDEMIA AND DIABETES MELLITUS” Sponsored By: Hypertension Institute Saint Thomas Medical Group Saint Thomas Hospital Nashville, Tennessee The Consortium for Southeastern Hypertension Control (COSEHC) Winston-Salem, North Carolina Thursday – Saturday, October 6-8, 2005 Offered At: Loews Vanderbilt Hotel 2100 West End Avenue Nashville, TN 37203 615-320-1700 Page 2 COURSE INFORMATION NEEDS ASSESSMENT/PURPOSE There have been rapid developments of new concepts in pathophysiology, diagnosis, clinical aspects and treatment of hypertension , obesity, dyslipidemia, diabetes mellitus, metabolic syndrome and associated CVD and TOD. Publication of many ...

Hypertension among bus drivers in the urban areas of Bangkok, Thailand Sumlee Saleekul M.S.( Public Health Nursing ),R.N. Deputy Director, Boromarajonani college of Nursing,Bangkok,Thailand Page 2 Traffic Jam Page 3 Page 4 Page 5 Page 6 Page 7 Objective To examine the prevalence of hypertension and its related factors among bus drivers working for the Bangkok Mass Transit Authority (BMTA). Page 8 Study Area Page 9 Research Methodology Research design: Cross sectional study Subjects : 435 male Bus drivers : 278 male age matched workers from rural ...

original article The new england journal of medicine n engl j med 350;9 www.nejm.org february 26, 2004 886 Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease Mark T. Gladwin, M.D., Vandana Sachdev, M.D., Maria L. Jison, M.D., Yukitaka Shizukuda, M.D., Ph.D., Jonathan F. Plehn, M.D., Karin Minter, M.D., Bernice Brown, M.D., Wynona A. Coles, R.R.T., James S. Nichols, R.N., Inez Ernst, R.N., B.S.N., R.D.C.S., Lori A. Hunter, R.N., William C. Blackwelder, Ph.D., Alan N. Schechter, M.D., Griffin P. Rodgers, M.D., Oswaldo Castro, M.D., and Frederick P. Ognibene, M.D. From the Critical Care Medicine Depart- ment, Clinical Center (M.T.G., M.L.J., K.M., W.A.C., J.S.N., I.E., L.A.H., W.C.B., F.P.O.), the Cardiovascular Branch, National Heart, Lung, and Blood Institute (M.T.G., V.S., Y.S., J.F.P., I.E.), ...

hypertension Prevention, Detection, Evaluation,and Treatment of Hypertension ; the JNC VI Report Brenda Hage, MSN, CRNP College Misericordia JNC VI Report Expert panel consensus statement on hypertension developed by the National High Blood Pressure Education Program Committee (NHBPEP), published Nov. 1997 Coordinated by the National Heart Lung Blood Institute (NHLBI), U.S. National Institutes of Health Public Health Goals Related to Hypertension (HTN) Prevent the rise of blood pressure with age Decrease the existing prevalence of HTN Increase hypertension awareness and detection Improve control of hypertension Reduce cardiovascular risks ...

The Second Australian National Blood Pressure Study Page 1 of 6 8/08/01 Background Outcome of treatment of hypertension Over the past 25 years studies of the drug treatment of mild-moderate hypertension have demonstrated that reduction of blood pressure is associated with reduction in the risk of cardiovascular morbidity and mortality. In middle-aged subjects with hypertension , the risk of fatal and non-fatal stroke is reduced by approximately 40%, which is the benefit predicted from epidemiological studies. In contrast the risk of coronary heart disease is reduced by only 10-15% compared to the potential benefit of approximately 20-25% predicted from epidemiological studies. More recently, studies in older subjects (>65 years if age) have demonstrated that the benefit of blood pressure reduction in hypertensive individuals extends at least to the age of 84 years. ...

Evidence Synthesis Number 34 Primary Care Screening for Ocular Hypertension and Primary Open-Angle Glaucoma: Evidence Synthesis Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. 290-02-0024 Task Order No. 2 Technical Support of the U.S. Preventive Services Task Force Prepared by: Oregon Evidence-based Practice Center Portland, Oregon Craig Fleming, MD Evelyn Whitlock, MD, MPH Tracy Beil, MS Barbara Smit, MD, PhD March 2005 Page 2 iii Preface The Agency for Healthcare Research and Quality (AHRQ) sponsors the development of Systematic Evidence Reviews (SERs) and Evidence Syntheses through its Evidence-based Practice Program. With guidance ...